Clear Cell
Sarcomas
NF2-mutant / YAP-Fusion
Cancers
KEAP1-mutant
Lung Cancers
MCTO
(Rare Disease)
Partner with
Arpeggio
Arpeggio is a team of leading experts in disease biology and drug discovery research. Our pipeline of unique small-molecule inhibitors were designed to probe biology on a systems level, getting to the heart of disease sooner.
Contact Us
Have questions? Interested in partnering with Arpeggio? Let us know.